drugset / Trial / NCT06032442

A Study to Assess Efficacy of Supporting Properties and Safety of ARTNEO in Patients With Knee Osteoarthritis

NCT06032442 ↗

Completed 70 enrolled NPO Petrovax
RandomizedParallel-groupOpen-labelSupportive care

Summary

The goal of the interventional study is to assess the effectiveness of the supporting properties and safety of the dietary supplement ARTNEO (ARTNEO®), capsules with an average weight of 585 mg, in patients with osteoarthritis of the knee joint of both sexes aged 40 to 75 years. The main questions it aims to answer are: 1. To evaluate the effectiveness of the supporting properties of dietary supplement ARTNEO (ARTNEO®) in patients with knee osteoarthritis in comparison with active control; 2. To evaluate the safety of the dietary supplement ARTNEO (ARTNEO®) in patients with knee osteoarthritis

Timeline

Start
2022-03-21
Primary completion
2023-05-18
Completion
2023-07-18

Drugs

EvaluationDrugModalityDoseRoute
Subject ARTNEO Unknown 585 mg —
Comparator Artra Unknown 500 mg Oral

Indications